Alembic Pharmaceuticals gets USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004%
Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.